


Pharmaceuticals & Biotechnology | Small Cap
Sunrest Lifescience Ltd demonstrates a mixed financial performance. The company shows strengths in profitability, driven by strong gross, operating, and net profit margins. Its coverage ratios are adequate, particularly regarding interest obligations. However, the company faces challenges in liquidity, growth, and efficiency, indicating potential difficulties in meeting short-term obligations and leveraging assets effectively. Financial ratios are also weak, suggesting limited earnings and book value per share. While the company's profitability and coverage offer some stability, addressing the weaknesses in liquidity, growth, efficiency, and financial metrics is crucial for sustained financial health and future success. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further impact the company's performance.
Sunrest Lifescience Ltd demonstrates a mixed financial performance. The company shows strengths in profitability, driven by strong gross, operating, and net profit margins. Its coverage ratios are adequate, particularly regarding interest obligations. However, the company faces challenges in liquidity, growth, and efficiency, indicating potential difficulties in meeting short-term obligations and leveraging assets effectively. Financial ratios are also weak, suggesting limited earnings and book value per share. While the company's profitability and coverage offer some stability, addressing the weaknesses in liquidity, growth, efficiency, and financial metrics is crucial for sustained financial health and future success. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further impact the company's performance.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
9.89
Industry Median
32.38
Small Cap Median
29.54
P/E RATIO
7.42
P/B RATIO
1.50
Industry Median
3.38
Small Cap Median
2.89
P/S RATIO
0.41
Industry Median
3.65
Small Cap Median
2.73
Others
PEG RATIO
0.03
EV/EBITDA RATIO
2.99
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹35.6 as on Jul 10, 2026.
The company's growth ratios are weak, indicating limited expansion in revenue, operating profit, earnings per share, assets, and net income. This raises concerns about the company's ability to capitalize on market opportunities and sustain long-term growth. Without significant growth, the company may struggle to attract investors and maintain its competitive position in the market. Strategic initiatives are needed to stimulate growth across various financial metrics.
| Growth Ratios | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue Growth Rate | 112 | |
| Operating Profit Growth Rate | 236.96 | |
| Earnings Per Share (EPS) Growth | 105.13 | |
| Asset Growth Rate | 21.76 | |
| Net Income Growth Rate | 296.04 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Sunrest Lifescience Ltd | 4.17 | 7.42 | Highly Undervalued | 10.21 | 3.60 | 8.00 |
| 2 | Ortin Global Ltd | 3.45 | -19.80 | Neutral | -0.72 | -0.91 | -0.74 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT